Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

BBH VanEck Vectors Biotech ETF

  • Fund Description

    VanEck Vectors Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 12/07/16

    • 30-Day SEC Yield1

      0.36%
    • Total Net Assets

      $547.8M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.40%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/16/2016
  • Portfolio Composition (%)
    as of 12/07/16

    • % of Net Assets
    • Stocks

      100.18
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.18
  • Daily HoldingsDaily Holdings (%) as of 12/07/16

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Amgen Inc
    AMGN US
    428,745
    60,534,50711.05
    Gilead Sciences Inc
    GILD US
    826,613
    60,160,89410.98
    Celgene Corp
    CELG US
    515,124
    58,033,87010.59
    Allergan Plc
    AGN US
    235,920
    44,761,1028.17
    Quintiles Ims Holdings Inc
    Q US
    471,132
    36,244,1856.62
    Biogen Inc
    BIIB US
    122,189
    34,860,5226.36
    Alexion Pharmaceuticals Inc
    ALXN US
    206,721
    25,968,2924.74
    Incyte Corp
    INCY US
    248,645
    25,351,8444.63
    Regeneron Pharmaceuticals Inc
    REGN US
    64,665
    23,409,3774.27
    Biomarin Pharmaceutical Inc
    BMRN US
    268,970
    21,791,9493.98
    Acadia Pharmaceuticals Inc
    ACAD US
    795,379
    21,538,8633.93
    Vertex Pharmaceuticals Inc
    VRTX US
    270,491
    20,373,3823.72
    Illumina Inc
    ILMN US
    152,488
    18,606,5863.40
    Qiagen Nv
    QGEN US
    490,262
    13,663,6022.49
    United Therapeutics Corp
    UTHR US
    82,313
    10,824,9831.98
    Alkermes Plc
    ALKS US
    177,667
    9,869,4021.80
    Tesaro Inc
    TSRO US
    72,566
    9,785,5251.79
    Seattle Genetics Inc
    SGEN US
    147,829
    9,622,1901.76
    Grifols Sa
    GRFS US
    644,355
    9,381,8091.71
    Charles River Laboratories Internationa
    CRL US
    119,410
    8,651,2551.58
    Ionis Pharmaceuticals Inc
    IONS US
    181,730
    8,359,5801.53
    Neurocrine Biosciences Inc
    NBIX US
    153,849
    6,606,2761.21
    Alnylam Pharmaceuticals Inc
    ALNY US
    123,683
    4,981,9510.91
    Bluebird Bio Inc
    BLUE US
    41,339
    2,914,4000.53
    Intercept Pharmaceuticals Inc
    ICPT US
    23,783
    2,462,4920.45
    Other/Cash
    --
    --
    -967,300-0.18
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.